Cargando…

The Calculation and Evaluation of an Ultrasound-Estimated Fat Fraction in Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease

We aimed to develop a non-linear regression model that could predict the fat fraction of the liver (UEFF), similar to magnetic resonance imaging proton density fat fraction (MRI-PDFF), based on quantitative ultrasound (QUS) parameters. We measured and retrospectively collected the ultrasound attenua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaposi, Pál Novák, Zsombor, Zita, Rónaszéki, Aladár D., Budai, Bettina K., Csongrády, Barbara, Stollmayer, Róbert, Kalina, Ildikó, Győri, Gabriella, Bérczi, Viktor, Werling, Klára, Maurovich-Horvat, Pál, Folhoffer, Anikó, Hagymási, Krisztina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648816/ https://www.ncbi.nlm.nih.gov/pubmed/37958249 http://dx.doi.org/10.3390/diagnostics13213353

Ejemplares similares

Evaluation of Artificial Intelligence-Calculated Hepatorenal Index for Diagnosing Mild and Moderate Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease
por: Zsombor, Zita, et al.
Publicado: (2023)

Tissue attenuation imaging and tissue scatter imaging for quantitative ultrasound evaluation of hepatic steatosis
por: Rónaszéki, Aladár D., et al.
Publicado: (2022)

Focal Liver Lesion MRI Feature Identification Using Efficientnet and MONAI: A Feasibility Study
por: Stollmayer, Róbert, et al.
Publicado: (2022)

Microvascular flow imaging to differentiate focal hepatic lesions: the spoke-wheel pattern as a specific sign of focal nodular hyperplasia
por: Rónaszéki, Aladár David, et al.
Publicado: (2023)

Diagnosis of focal liver lesions with deep learning-based multi-channel analysis of hepatocyte-specific contrast-enhanced magnetic resonance imaging
por: Stollmayer, Róbert, et al.
Publicado: (2021)

Radiomics analysis of contrast-enhanced CT scans can distinguish between clear cell and non-clear cell renal cell carcinoma in different imaging protocols
por: Budai, Bettina Katalin, et al.
Publicado: (2022)

Three-dimensional CT texture analysis of anatomic liver segments can differentiate between low-grade and high-grade fibrosis
por: Budai, Bettina Katalin, et al.
Publicado: (2020)

Cerebral iodized lipid embolization via a pulmonary arteriovenous shunt: rare complication of transcatheter arterial embolization for hepatocellular carcinoma
por: Bánsághi, Zoltán, et al.
Publicado: (2013)

Diffusion weighted magnetic resonance imaging demonstrates tumor response following palliative embolization of a recurrent shoulder plasmacytoma
por: Bérczi, Viktor, et al.
Publicado: (2014)

Effectiveness of COVID-19 Vaccination with mRNA Vaccines for Patients with Cirrhosis in Hungary: Multicentre Matched Cohort Study
por: Drácz, Bálint, et al.
Publicado: (2022)

Hypocalcemia on Admission Is a Predictor of Disease Progression in COVID-19 Patients with Cirrhosis: A Multicenter Study in Hungary
por: Drácz, Bálint, et al.
Publicado: (2023)

The Elevated De Ritis Ratio on Admission Is Independently Associated with Mortality in COVID-19 Patients
por: Drácz, Bálint, et al.
Publicado: (2022)

Is Hepatocellular Carcinoma in Fatty Liver Different to Non-Fatty Liver?
por: Nguyen, Xuan-vinh Kevin, et al.
Publicado: (2022)

Current role of coronary calcium in younger population and future prospects with photon counting technology
por: Cademartiri, Filippo, et al.
Publicado: (2022)

Spatial Systems Lipidomics Reveals Nonalcoholic Fatty Liver Disease Heterogeneity
por: Ščupáková, Klára, et al.
Publicado: (2018)

Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity
por: Pal, Partha, et al.
Publicado: (2021)

Fatty liver in children
por: Rafeey, Mandana, et al.
Publicado: (2009)

Impact of a Targeted Project for Shortening of Imaging Diagnostic Waiting Time in Patients with Suspected Oncological Diseases in Hungary
por: Papp, Zsombor Mátyás, et al.
Publicado: (2023)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
por: Wang, Xin, et al.
Publicado: (2011)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)

Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
por: Wibawa, I Dewa Nyoman, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers
por: Anavi, Sarit, et al.
Publicado: (2017)

Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population
por: Cho, Eun-Ju, et al.
Publicado: (2021)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Comparison of Machine Learning Models and the Fatty Liver Index in Predicting Lean Fatty Liver
por: Su, Pei-Yuan, et al.
Publicado: (2023)

Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis
por: Pal, Shreya C, et al.
Publicado: (2023)

Acute Fatty Liver of Pregnancy
por: Dey, Madhusudan, et al.
Publicado: (2012)

Case of Fatty Malarial Liver
por: Buchanan, W. J.
Publicado: (1898)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Thin Patient, Fatty Liver
por: Mukthinuthalapati, V V Pavan Kedar, et al.
Publicado: (2019)

Acute Fatty Liver of Pregnancy
por: Ademiluyi, Ademayowa, et al.
Publicado: (2021)

Curing Fatty Liver with Oxysterols?
por: Uehara, Kahealani, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Identification of Hepatic Dendritic Cells in Liver Biopsies in Patients with Metabolic Dysfunction-Associated Fatty Liver Diseas (MAFLD) and Obesity
por: Barranco-Fragoso, Beatriz, et al.
Publicado: (2022)

Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese
por: Huang, Xiaolin, et al.
Publicado: (2015)

Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?
por: Plaz Torres, Maria Corina, et al.
Publicado: (2020)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
por: Han, A Lum
Publicado: (2022)

Role of bioactive fatty acids in nonalcoholic fatty liver disease
por: Juárez-Hernández, Eva, et al.
Publicado: (2016)

Acute fatty liver of pregnancy simulating liver tumor
por: Anon, Benjamin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3mv630feae58clifjfdb96ulb8